Investing
Republic Services (RSG) to report Q1 Earnings: What to Expect?
Republic Services, Inc. RSG is scheduled to release its first-quarter 2024 results on Apr 30, after market close. RSG has an impressive earnings surprise ...
5 Stocks From the Thriving Insurance Brokerage Industry
The Zacks Insurance Brokerage industry is likely to benefit from better pricing, prudent underwriting, rising demand for insurance products and global expansion. Industry players ...
AT&T (T) Q1 Earnings Beat Estimates, Revenues Remain Flat Y/Y
AT&T Inc. T reported modest first-quarter 2024 results, as solid wireless traction and customer additions were partially offset by lower demand for legacy voice ...
AT&T (T) Q1 Earnings Beat Estimates, Revenues Remain Flat Y/Y
AT&T Inc. T reported modest first-quarter 2024 results, as solid wireless traction and customer additions were partially offset by lower demand for legacy voice ...
Old Dominion (ODFL) Q1 Earnings Beat Estimates, Rise Y/Y
Old Dominion Freight Line’s ODFL first-quarter 2024 earnings per share of $1.34 surpassed the Zacks Consensus Estimate of $1.33 and increased 3.9% year over ...
Roper (ROP) Gears Up to Post Q1 Earnings: What to Expect?
Roper Technologies, Inc. ROP is scheduled to release first-quarter 2024 results on Apr 26, before market open. The Zacks Consensus Estimate for Roper’s first-quarter ...
PSEG (PEG) to Report Q1 Earnings: Here’s What to Expect
Public Service Enterprise Group Incorporated PEG, or PSEG, is slated to report first-quarter 2024 results on Apr 30 before market open. The company delivered ...
Interpublic (IPG) Q1 Earnings Meet Estimates, Decline Y/Y
The Interpublic Group of Companies, Inc. IPG has reported mixed first-quarter 2024 results, wherein earnings met the Zacks Consensus Estimate, whereas revenues beat the ...
What’s in Store for Charter Communications (CHTR) in Q1 Earnings?
Charter Communications CHTR is set to report its first-quarter 2024 results on Apr 26. The Zacks Consensus Estimate for first-quarter 2024 revenues is pegged ...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
After a rather weak 2023, the drug and biotech sector made a comeback initially in 2024 amid a slew of takeover deals. However, the ...
